Harm Tiddens

828 total citations
26 papers, 377 citations indexed

About

Harm Tiddens is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Molecular Biology. According to data from OpenAlex, Harm Tiddens has authored 26 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 4 papers in Nephrology and 2 papers in Molecular Biology. Recurrent topics in Harm Tiddens's work include Cystic Fibrosis Research Advances (16 papers), Neonatal Respiratory Health Research (13 papers) and Tracheal and airway disorders (7 papers). Harm Tiddens is often cited by papers focused on Cystic Fibrosis Research Advances (16 papers), Neonatal Respiratory Health Research (13 papers) and Tracheal and airway disorders (7 papers). Harm Tiddens collaborates with scholars based in Netherlands, United Kingdom and United States. Harm Tiddens's co-authors include R. A. Donckerwolcke, Marc Abramowicz, Bruce Barron, Osamu Kobayashi, G. C. Arneil, Ira Greifer, Chester M. Edelmann, N Hallman, Henry L. Barnett and Behrouz Kassaï and has published in prestigious journals such as The Lancet, Archives of Disease in Childhood and The Lancet Respiratory Medicine.

In The Last Decade

Harm Tiddens

26 papers receiving 344 citations

Peers

Harm Tiddens

NEPHR

PRM

PFM

PPCH

J P Wauters Switzerland

Anneke Bech Netherlands

Hédi Ben Maïz Tunisia

Luigi Cirillo Italy

Vittoria Esposito Italy

Franz Schaefer Germany

Laura Rivoli Italy

Titi Chen Australia

Hua Zhou China

Hidehisa Kitada Japan

J P Wauters Switzerland

Harm Tiddens

219 ×1.5

NEPHR

86 ×0.8

PRM

97 ×1.2

14 ×0.3

PFM

31 ×0.8

PPCH

Citations per year, relative to Harm Tiddens Harm Tiddens (= 1×) peers J P Wauters

Countries citing papers authored by Harm Tiddens

Since Specialization

Citations

This map shows the geographic impact of Harm Tiddens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harm Tiddens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harm Tiddens more than expected).

Fields of papers citing papers by Harm Tiddens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harm Tiddens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harm Tiddens. The network helps show where Harm Tiddens may publish in the future.

Co-authorship network of co-authors of Harm Tiddens

This figure shows the co-authorship network connecting the top 25 collaborators of Harm Tiddens. A scholar is included among the top collaborators of Harm Tiddens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harm Tiddens. Harm Tiddens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ciet, Pierluigi, et al.. (2025). Validation of an artificial intelligence-based automated PRAGMA and mucus plugging algorithm in pediatric cystic fibrosis. Journal of Cystic Fibrosis. 24(5). 970–978. 1 indexed citations

Horati, Hamed, Camilla Margaroli, Joshua D. Chandler, et al.. (2024). Key inflammatory markers in bronchoalveolar lavage predict bronchiectasis progression in young children with CF. Journal of Cystic Fibrosis. 23(3). 450–456. 5 indexed citations

Elnazir, B., Michael Williamson, D. Cox, et al.. (2024). WS15.05 Improvements in structural lung disease in people with CF aged 12 and above on elexacaftor/tezacaftor/ivacaftor are sustained for up to two years. Journal of Cystic Fibrosis. 23. S29–S29. 1 indexed citations

Ware, Robert S., et al.. (2021). 577: Outcomes from COMBAT CF: A phase 3 multicenter, randomized, placebo-controlled trial of azithromycin in primary prevention of radiologically defined bronchiectasis in infants with cystic fibrosis. Journal of Cystic Fibrosis. 20. S274–S274. 1 indexed citations

Tiddens, Harm, Eleni‐Rosalina Andrinopoulou, Stephanie D. Davis, et al.. (2021). 539: Effect of inhaled hypertonic saline on structural lung disease in preschool children with cystic fibrosis. The SHIP-CT study. Journal of Cystic Fibrosis. 20. S255–S255. 2 indexed citations

Horati, Hamed, Hettie M. Janssens, Camilla Margaroli, et al.. (2020). Airway profile of bioactive lipids predicts early progression of lung disease in cystic fibrosis. Journal of Cystic Fibrosis. 19(6). 902–909. 14 indexed citations

Gustafsson, Per, et al.. (2019). Risk factors for progression of structural lung disease in school-age children with cystic fibrosis. Journal of Cystic Fibrosis. 19(6). 910–916. 14 indexed citations

Ciet, Pierluigi, et al.. (2019). A clinical guide in the structured assessment of CT-imaging in congenital lung abnormalities. OA3609–OA3609. 1 indexed citations

Dompeling, Edward, J.L. Yntema, Bert Arets, et al.. (2015). Clinical evaluation of the Nanoduct sweat test system in the diagnosis of cystic fibrosis after newborn screening. European Journal of Pediatrics. 174(8). 1025–1034. 25 indexed citations

10.

Boeck, K. De, Harm Tiddens, J.S. Elborn, & Isabelle Fajac. (2013). A new Clinical Trials Directive to boost academic trials?. The Lancet Respiratory Medicine. 1(2). 99–101. 2 indexed citations

11.

Cornu, Catherine, Behrouz Kassaï, Roland Fisch, et al.. (2013). Experimental designs for small randomised clinical trials: an algorithm for choice. Orphanet Journal of Rare Diseases. 8(1). 48–48. 76 indexed citations

12.

Vos, Wim, et al.. (2013). Airway surface liquid concentrations of aztreonam lysine for inhalation in children with cystic fibrosis: a modelling study. Ghent University Academic Bibliography (Ghent University). 1 indexed citations

13.

Boeck, K. De, Veerle Bulteel, Harm Tiddens, et al.. (2011). Guideline on the design and conduct of cystic fibrosis clinical trials: The European Cystic Fibrosis Society–Clinical Trials Network (ECFS-CTN). Journal of Cystic Fibrosis. 10. S67–S74. 16 indexed citations

14.

Ciompi, Francesco, Martine Loeve, Oriol Pujol, et al.. (2011). Lung tissue classification in severe advanced cystic fibrosis from CT scans. Research at the University of Copenhagen (University of Copenhagen). 3 indexed citations

15.

Mott, Lauren S., et al.. (2011). Comparison of cystic fibrosis structural lung disease detected by inspiratory and expiratory chest CT scans in infants and preschool children. 38. 4658. 1 indexed citations

16.

Hughes, Dez, Harm Tiddens, & Jim M. Wild. (2009). Lung Imaging in Cystic Fibrosis. Data Archiving and Networked Services (DANS). 13(1). 28–37. 2 indexed citations

17.

Loeve, Martine, Maarten H. Lequin, Marleen de Bruijne, et al.. (2008). Volumetric ultra low dose expiratory computed tomography scans could be sufficient to monitor CF lung disease. Journal of Cystic Fibrosis. 7. S59–S59. 1 indexed citations

18.

Loeve, Martine, et al.. (2007). 158 Nocturnal cough frequency in children with cystic fibrosis. Journal of Cystic Fibrosis. 6. S38–S38. 1 indexed citations

19.

Hop, W.C.J., et al.. (2006). 355 Playing the board game “Airway” with children increases knowledge about CF lung disease. Journal of Cystic Fibrosis. 5. S78–S78. 1 indexed citations

20.

Donckerwolcke, R. A., et al.. (1970). Therapy of Bicarbonate-losing Renal Tubular Acidosis. Archives of Disease in Childhood. 45(244). 774–779. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact